RecruitingNCT06197724

MCG for Identification of Myocardial Ischemia in Suspected NSTE-ACS Patients

Magnetocardiography as an Innovative Diagnostic Tool for Early and Accurate Identification of Myocardial Ischemia in Suspected NSTE-ACS Patients

Sponsor

Qilu Hospital of Shandong University

Enrollment

14,090 participants

Start Date

Jan 2, 2024

Study Type

OBSERVATIONAL

Conditions

Non ST Segment Elevation Acute Coronary Syndrome

Summary

The goal of this multi-center observational study is to learn about the effectiveness of magnetocardiography in rapid and accurate identification of ischemia in patients with suspected NSTE-ACS.

Eligibility

Min Age: 18 Years

Inclusion Criteria3

Age 18 years or older;
Patients with symptoms of myocardial ischemia such as angina who are suspected to NSTE-ACS and proposed to undergo CAG or coronary CTA;
Signed informed consent.

Exclusion Criteria7

Patients with ST-elevation myocardial infarction (STEMI);
Patients with Non-ischemic dilated cardiomyopathy, or hypertrophic cardiomyopathy, or moderate or severe valvular disease;
Patients with Hemodynamic instability (systolic blood pressure<90 mmHg, or who requires vasoactive drugs), or patients with tachyarrhythmia, Ⅱ degree atrioventricular block and above that have not returned to normal;
Patients who have severe renal abnormality with eGFR <30 ml/min, or patients who are on dialysis;
Patients with malignant tumors with predicted survival of less than 1 year;
Pregnant or breastfeeding women;
Patients who are unable to enter the MCG device, who are unable to perform MCG examination due to interference from metal implants or other reasons, or who are deemed by the investigators to be unsuitable for enrollment.